Molecular Human Reproduction, Vol. 8, No. 8, 719-721,
August 2002
© 2002 European Society of Human Reproduction and Embryology
Testis and spermatogenesis |
Can mitochondrial DNA mutations cause sperm dysfunction?
1 Departments of Reproductive Medicine and 2 Neurology, The University of Newcastle-upon-Tyne, UK
| Abstract |
|---|
|
|
|---|
Very low levels of somatic mitochondrial (mt)DNA deletions have been identified in the semen of infertile men. It has been suggested that these mutations cause infertility through an effect on sperm motility, but there has been no direct evidence to show that mutant mtDNA can affect sperm function. We have carried out semen analysis on a male harbouring the A3243G mtDNA mutation and show that high levels of mutant mtDNA strongly correlate with low sperm motility.
infertility/MELAS/mitochondrial encephalomyopathy/mtDNA/sperm
| Introduction |
|---|
|
|
|---|
Infertility affects 1015% of couples. In 40% of cases, this is primarily due to the male and is related to sperm motility (asthenozoospermia) or sperm number (oligospermia) (Baker, 1994
gene (Rovio et al., 2001
Low levels of mtDNA mutations have been identified in the semen of males seeking medical help for their infertility problem (Kao et al., 1995
, 1998
; Lestienne et al., 1997
; St John et al., 2001
). This raises the possibility that acquired mtDNA mutations might contribute to age-related sperm dysmotility, and the consequent decline in male reproductive capacity seen with advancing age (Cummins et al., 1994
). Although this hypothesis is attractive, there has been no direct evidence to show that mutant mtDNA actually causes defective sperm motility, and not all studies have shown a clear relationship between male infertility and the proportion of mutant mtDNA in semen specimens (Cummins et al., 1998
).
Inherited mtDNA mutations are a common cause of multisystem disease (DiMauro and Schon, 2001
). Patients with mtDNA disease usually harbour a mixture of mutant and wild-type mtDNA in the same tissue (heteroplasmy). In-vitro and single cell studies have shown that individual cells must contain a high percentage level of mutant mtDNA before they express a respiratory chain defect (Larsson and Clayton, 1995
), and the severity of the neurological clinical phenotype in patients with mtDNA disease correlates with the percentage of mutant mtDNA in clinically relevant tissues (Chinnery et al., 1997a
; White et al., 1999
). To explore the possible relationship between mutant mtDNA and sperm motility we studied two independent semen samples obtained from a male who had inherited the A3243G mtDNA from his mother [index case reported in Chinnery et al. (Chinnery et al., 1997b
)]. We separated each semen sample into different fractions based upon sperm motility and measured the percentage of mutant mtDNA (mutation load) in each sperm fraction.
| Materials and methods |
|---|
|
|
|---|
Concentration, motility and sperm kinematics were determined on each sample using a 20 µm deep Microcell chamber and a Computer Assisted Sperm Analysis (CASA) system (Hobson Sperm Tracker, software version 7.01). For each analysis 200 sperm were studied, each for a minimum of 1 s, with a sampling frequency of 25 Hz. We were particularly interested in the percentage of sperm capable of fertilization (motility classes a and b), the curvilinear velocity (VCL) and the average path velocity (VAP) of sperm because these parameters reflect sperm oxidative metabolism (Ruiz-Pesini et al., 1998
32-P dCTP was added before the last cycle of the reaction. The presence of the A3243G mutation creates an additional HaeIII restriction site within the amplified fragment. The PCR products were therefore digested with the restriction endonuclease HaeIII (Roche) before separation on a 6% non-denaturing polyacrylamide gel. Mutation load was determined by phosphorimage analysis (Molecular Dynamics). | Results |
|---|
|
|
|---|
The semen volume was within the normal range, but the concentration and motility were below normal for both samples (World Health Organization, 1999
|
|
| Discussion |
|---|
|
|
|---|
Our observations provide direct evidence that a mtDNA mutation can cause sperm dysfunction. Reduced sperm motility has been previously noted in a patient with mtDNA disease due to the A3243G mtDNA mutation (Folgero et al., 1993
How can we explain the apparent linear relationship between sperm kinematics and the percentage level of mutant mtDNA? There are a number of possibilities. Each fraction of semen separated by the Percoll gradient contains a mixed population of sperm with different levels of motility. Higher concentrations of Percoll will enrich for highly motile sperm (with a corresponding low mutation load), but many motile sperm will also still remain in the lower concentrations of Percoll, effectively `diluting' the level of the A3243G mutation at that level. An alternative explanation is that the threshold level for the A3243G mutation is much lower in vivo than in vitro. In cybrid cell lines, a biochemical defect was only present in those harbouring >90% A3243G mutation (Chomyn et al., 1992
), but in-vivo studies using 31P-MRS have shown that very low levels of the A3243G mutation may cause a defect of mitochondrial energy metabolism (Chinnery et al., 2000a
) and therefore lower levels of mutant mtDNA (
50%) may compromise sperm function in vivo. Only 5% of the sperm in the top Percoll fraction had motility adequate for fertilization, and the mean percentage level of mutant mtDNA in this fraction was 64% (Figure 1
). It is worth noting, however, that an asymptomatic Chinese individual harboured 38% A3243G mutation in his semen and had normal sperm motility (Huang et al., 1994
).
Normal semen contains a small number of leukocytes that may influence the amount of mutant mtDNA, and the patient studied here had very low levels (4%) of mutant mtDNA in his leukocytes (Chinnery et al., 1997b
). However, the proportion of leukocytes to sperm in semen is extremely low (<1x106/ml) and it is therefore very unlikely that the leukocyte mtDNA had a major effect on the semen mtDNA analysis reported here (sperm concentration 12.37 and 16.50x106/ml).
The traditional view is that the level of pathogenic heteroplasmic mtDNA mutations tends to be low in rapidly dividing tissues and high in non-dividing tissues. Our observations of human sperm show that this need not necessarily be the case, and factors other than mitotic activity modulate cellular mutation load (Dubeau et al., 2000
; Battersby and Shoubridge, 2001
).
| Acknowledgements |
|---|
|
|
|---|
We are grateful to Denise Brown for her assistance. P.F.C. and D.M.T. are supported by the Wellcome Trust.
| Notes |
|---|
3 To whom correspondence should be addressed at: Department of Neurology, The Medical School, Framlington Place, Newcastle-upon-Tyne, NE2 4HH, UK. E-mail: p.f.chinnery{at}ncl.ac.uk
| References |
|---|
|
|
|---|
Baker, H.W. (1994) Clinical male infertility. II. Critical evaluation and prospects for therapy. Reprod. Fertil. Dev., 6, 912.[Medline]
Battersby, B.J. and Shoubridge, E. (2001) Selection of a mtDNA sequence variant in hepatocytes of heteroplasmic mice is not due to difference in respiratory chain function or efficiency of replication. Hum. Mol. Genet., 10, 24692479.
Chinnery, P., Howell, N., Lightowlers, R. and Turnbull, D. (1997a) Molecular pathology of MELAS and MERRF: the relationship between mutation load and clinical phenotype. Brain, 120, 17131721.
Chinnery, P.F., Reading, P.J., Walls, T.J. and Turnbull, D.M. (1997b) Recurrent strokes in a 34 year old man. Lancet, 350, 560.[Web of Science][Medline]
Chinnery, P.F., Zwijnenburg, P.J.G., Howell, N., Lightowlers, R.N., Bindoff, L., Taylor, R.W., Walker, M. and Turnbull, D.M. (1999) Non-random tissue distribution of mutant mitochondrial DNA. Am. J. Med. Genet., 85, 498501.[Web of Science][Medline]
Chinnery, P.F., Taylor, D.J., Brown, D.T., Manners, D., Styles, P. and Lodi, R. (2000a) Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo. Ann. Neurol., 47, 3814.[Web of Science][Medline]
Chinnery, P.F., Johnson, M.A., Wardell, T.M., Singh-Kler, R., Hayes, C., Brown, D.T., Taylor, R.W., Bindoff, L.A. and Turnbull, D.M. (2000b) Epidemiology of pathogenic mitochondrial DNA mutations. Ann. Neurol., 48, 188193.[Web of Science][Medline]
Chomyn, A., Martinuzzi, A., Yoneda, M., Daga, A., Hurko, O., Johns, D., Lai, S.T., Nonaka, I., Angelini, C. and Attardi, G. (1992) MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. Proc. Natl Acad. Sci. USA, 89, 42214225.
Cummins, J.M., Jequier, A.M. and Kan, R. (1994) Molecular biology of human male infertility: links with aging, mitochondrial genetics and oxidative stress. Mol. Reprod. Dev., 37, 345362.[Web of Science][Medline]
Cummins, J.M., Jequier, A.M., Martin, R. Mehmet, D. and Goldblatt, J. (1998) Semen levels of mitochondrial DNA deletions in men attending an infertility clinic do not correlate with phenotype. Int. J. Androl., 21, 4752.[Web of Science][Medline]
DiMauro, S. and Schon, E.A. (2001) Mitochondrial DNA mutations in human disease. Am. J. Med. Genet., 106, 1826.[Web of Science][Medline]
Dubeau, F., De Stefano, N., Zifkin, B.G., Arnold, D.L. and Shoubridge, E.A. (2000) Oxidative phosphorylation defect in the brains of carriers of the tRNAleu (UUR) A3243G mutation in a MELAS pedigree. Ann. Neurol., 47, 179185.[Web of Science][Medline]
Fadic, R., Russell, J.A., Vedanarayanan, V.V., Lehar, M., Kuncl, R.W. and Johns, D.R. (1997) Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology, 49, 239245.
Folgero, T., Bertheussen, K., Lindal, S., Torbergsen, T. and Oian, P. (1993) Mitochondrial disease and reduced sperm motility. Hum. Reprod., 8, 18631868.
Folgero, T., Torbergsen, T. and Oian, P. (1995) The 3243 MELAS mutation in a pedigree with MERRF. Eur. Neurol., 35, 168171.[Web of Science][Medline]
Huang, C.C., Chen, R.S., Chen, C.M., Wang, H.S., Lee, C.C., Pang, C.Y., Hsu, H.S., Lee, H.C. and Wei, Y.H. (1994) MELAS syndrome with mitochondrial tRNA (Leu (UUR)) gene mutation in a Chinese family. J. Neurol. Neurosurg. Psychiatry, 57, 586589.
Kao, S.-H., Chao, H.-T. and Wei, Y.-H. (1995) Mitochondrial deoxyribonucleic acid 4977-bp deletion is associated with diminished fertility and motility of human sperm. Biol. Reprod., 52, 729736.[Abstract]
Kao, S.H., Chao, H.-T. and Wei, J.Y. (1998) Multiple deletions of mitochondrial DNA are associated with the decline of motility and fertility of human spermatozoa. Mol. Hum. Reprod., 4, 657666.
Larsson, N.G. and Clayton, D.A. (1995) Molecular genetic aspects of human mitochondrial disorders. Ann. Rev. Genet., 29, 151178.[Web of Science][Medline]
Lestienne, P., Reynier, P. and Chretien, M.F., Penisson-Besnier, I., Malthiery, Y., Rohmer, V. (1997) Oligoasthenospermia associated with multiple mitochondrial DNA rearrangements. Mol. Hum. Reprod., 3, 811814.
Rovio, A.T., Marchington, D., Donat, S., Schuppe, H.-C., Abel, J., Fritsche, E., Elliot, D.J., Liappala, P., Ahola, A.L., McNay, D. et al. (2001) Mutations at the mitochondrial DNA polymerase (POLG) locus associated with male infertility. Nature Genet., 29, 261262.[Web of Science][Medline]
Ruiz-Pesini, E., Diez, C., Lapena, A.C., Perez-Martos, A., Montoya, J., Alvarez, E., Arenas, J. and Lopez-Perez, M.J. (1998) Correlation of sperm motility with mitochondrial enzymatic activities. Clin. Chem., 44, 16161620.
Ruiz-Pesini, E., Lapena, A.-C., Diez-Sanchez, C., Perez-Martos, A., Montoya, J., Alvarez, E., Diaz, M., Urries, A., Montoro, L., Lopez-Perez, M.J. et al. (2000) Human mtDNA haplogroups associated with a high or reduced spermatozoa motility. Am. J. Hum. Genet., 67, 682696.[Web of Science][Medline]
St John, J.C., Jokhi, R.P. and Barratt, C.L.R. (2001) Men with oligoasthenoteratozoospermia harbour higher numbers of multiple mitochondrial deletions in their spermatozoa, but individual deletions are not indicative of their overall aetiology. Hum. Mol. Reprod., 7, 103111.
White, S.L., Collins, V.R., Wolfe, R., Cleary, M.A., Shanske, S., DiMauro, S., Dahl, H.H. and Thorburn, D.R. (1999) Genetic counseling and prenatal diagnosis for the mitochondrial DNA mutations at nucleotide 8993. Am. J. Hum. Genet., 65, 47482.[Web of Science][Medline]
World Health Organization (1999) WHO Laboratory Manual for the Evaluation of Human Semen and SemenCervical Mucus Interaction, 4th edn. Cambridge University Press, Cambridge, UK.
Submitted on February 7, 2002; accepted on May 16, 2002.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Xu, S. Z. DeLuca, and P. H. O'Farrell Manipulating the Metazoan Mitochondrial Genome with Targeted Restriction Enzymes Science, July 25, 2008; 321(5888): 575 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Fujita, J. L. Boore, and C. Moritz Multiple Origins and Rapid Evolution of Duplicated Mitochondrial Genes in Parthenogenetic Geckos (Heteronotia binoei; Squamata, Gekkonidae) Mol. Biol. Evol., December 1, 2007; 24(12): 2775 - 2786. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Brower, N. Rodic, T. Seki, M. Jorgensen, N. Fliess, A. T. Yachnis, J. R. McCarrey, S. P. Oh, and N. Terada Evolutionarily Conserved Mammalian Adenine Nucleotide Translocase 4 Is Essential for Spermatogenesis J. Biol. Chem., October 5, 2007; 282(40): 29658 - 29666. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.M. Agbaje, D.A. Rogers, C.M. McVicar, N. McClure, A.B. Atkinson, C. Mallidis, and S.E.M. Lewis Insulin dependant diabetes mellitus: implications for male reproductive function Hum. Reprod., July 1, 2007; 22(7): 1871 - 1877. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Amaral, J. Ramalho-Santos, and J. C. St John The expression of polymerase gamma and mitochondrial transcription factor A and the regulation of mitochondrial DNA content in mature human sperm Hum. Reprod., June 1, 2007; 22(6): 1585 - 1596. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakada, A. Sato, K. Yoshida, T. Morita, H. Tanaka, S.-I. Inoue, H. Yonekawa, and J.-I. Hayashi Mitochondria-related male infertility PNAS, October 10, 2006; 103(41): 15148 - 15153. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.C. Spikings, J. Alderson, and J.C.St. John Transmission of mitochondrial DNA following assisted reproduction and nuclear transfer Hum. Reprod. Update, July 1, 2006; 12(4): 401 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Engelstadter and S. Charlat Outbreeding selects for spiteful cytoplasmic elements Proc R Soc B, April 22, 2006; 273(1589): 923 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.J.A.M. Jacobs, G. de Wert, J.P.M. Geraedts, I.F.M. de Coo, and H.J.M. Smeets The transmission of OXPHOS disease and methods to prevent this Hum. Reprod. Update, March 1, 2006; 12(2): 119 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gianotten, M.P. Lombardi, A.H. Zwinderman, R. J. Lilford, and F. van der Veen Idiopathic impaired spermatogenesis: genetic epidemiology is unlikely to provide a short-cut to better understanding Hum. Reprod. Update, November 1, 2004; 10(6): 533 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. St. John and G. Schatten Paternal Mitochondrial DNA Transmission During Nonhuman Primate Nuclear Transfer Genetics, June 1, 2004; 167(2): 897 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jensen, H. Leffers, J. H. Petersen, A. Nyboe Andersen, N. Jorgensen, E. Carlsen, T. K. Jensen, N. E. Skakkebaek, and E. Rajpert-De Meyts Frequent polymorphism of the mitochondrial DNA polymerase gamma gene (POLG) in patients with normal spermiograms and unexplained subfertility Hum. Reprod., January 1, 2004; 19(1): 65 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Thangaraj, M. B. Joshi, A. G. Reddy, A. A. Rasalkar, and L. Singh Sperm Mitochondrial Mutations as a Cause of Low Sperm Motility J Androl, May 1, 2003; 24(3): 388 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Longhurst, J. D. Jacobs, M. M. White, J. T. Crossno Jr., D. A. Fitzgerald, J. Bao, T. J. Fitzgerald, R. Raghow, and L. K. Jennings Chinese Hamster Ovary Cell Motility to Fibronectin Is Modulated by the Second Extracellular Loop of CD9. IDENTIFICATION OF A PUTATIVE FIBRONECTIN BINDING SITE J. Biol. Chem., August 30, 2002; 277(36): 32445 - 32452. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||









